Suppr超能文献

特异性抑制 PI3K p110δ 抑制 CSF-1 诱导的巨噬细胞铺展和侵袭能力。

Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.

机构信息

School of Medicine and Pharmacology, The University of Western Australia, Crawley, Western Australia, Australia.

出版信息

FEBS J. 2013 Nov;280(21):5228-36. doi: 10.1111/febs.12316. Epub 2013 Jun 5.

Abstract

Colony stimulating factor-1 (CSF-1) stimulates mononuclear phagocytic cell survival, growth and differentiation into macrophages through activation and autophosphorylation of the CSF-1 receptor (CSF-1R). We have previously demonstrated that CSF-1-induced phosphorylation of Y721 (pY721) in the receptor kinase insert triggers its association with the p85 regulatory subunit of phosphoinositide 3'-kinase (PI3K). Binding of p85 PI3K to the CSF-1R pY721 motif activates the associated p110 PI3K catalytic subunit and stimulates spreading and motility in macrophages and enhancement of tumor cell invasion. Here we show that pY721-based signaling is necessary for CSF-1-stimulated PtdIns(3,4,5)P production. While primary bone marrow-derived macrophages and the immortalized bone marrow-derived macrophage cell line M-/-.WT express all three class IA PI3K isoforms, p110δ predominates in the cell line. Treatment with p110δ-specific inhibitors demonstrates that the hematopoietically enriched isoform, p110δ, mediates CSF-1-regulated spreading and invasion in macrophages. Thus GS-1101, a potent and selective p110δ inhibitor, may have therapeutic potential by targeting the infiltrative capacity of tumor-associated macrophages that is critical for their enhancement of tumor invasion and metastasis.

摘要

集落刺激因子 1(CSF-1)通过激活和自身磷酸化 CSF-1 受体(CSF-1R)来刺激单核吞噬细胞的存活、生长和分化为巨噬细胞。我们之前已经证明,受体激酶插入位点的 CSF-1 诱导的 Y721 磷酸化(pY721)触发其与磷酸肌醇 3'-激酶(PI3K)的 p85 调节亚基结合。p85 PI3K 与 CSF-1R pY721 基序的结合激活相关的 p110 PI3K 催化亚基,并刺激巨噬细胞的扩展和迁移以及增强肿瘤细胞的侵袭。在这里,我们表明基于 pY721 的信号传导对于 CSF-1 刺激的 PtdIns(3,4,5)P 产生是必需的。虽然原代骨髓来源的巨噬细胞和永生化的骨髓来源的巨噬细胞系 M-/-WT 表达所有三种 IA 类 PI3K 同工型,但 p110δ 在细胞系中占主导地位。用 p110δ 特异性抑制剂处理表明,造血丰富的同工型 p110δ 介导 CSF-1 调节的巨噬细胞扩展和侵袭。因此,GS-1101 是一种有效的、选择性的 p110δ 抑制剂,通过靶向肿瘤相关巨噬细胞的浸润能力,具有治疗潜力,而这种浸润能力对于增强肿瘤侵袭和转移至关重要。

相似文献

1
Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.
FEBS J. 2013 Nov;280(21):5228-36. doi: 10.1111/febs.12316. Epub 2013 Jun 5.
3
Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
J Cell Sci. 2008 Dec 15;121(Pt 24):4124-33. doi: 10.1242/jcs.032763. Epub 2008 Nov 25.
4
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
Blood. 2010 Sep 2;116(9):1460-8. doi: 10.1182/blood-2009-06-222943. Epub 2010 May 26.
6
Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110δ isoform of PI 3-kinase.
FASEB J. 2012 Feb;26(2):691-706. doi: 10.1096/fj.11-189753. Epub 2011 Nov 11.
8
CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.
Cell Signal. 2016 Sep;28(9):1325-1335. doi: 10.1016/j.cellsig.2016.05.013. Epub 2016 May 17.

引用本文的文献

1
The role of macrophage migratory behavior in development, homeostasis and tumor invasion.
Front Immunol. 2024 Nov 11;15:1480084. doi: 10.3389/fimmu.2024.1480084. eCollection 2024.
2
Focus on Pancreatic Cancer Microenvironment.
Curr Oncol. 2024 Jul 26;31(8):4241-4260. doi: 10.3390/curroncol31080316.
3
Mechanisms of Altered Immune Response in Skin Melanoma.
Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30.
4
PI3K Isoform Immunotherapy for Solid Tumours.
Curr Top Microbiol Immunol. 2022;436:369-392. doi: 10.1007/978-3-031-06566-8_16.
5
Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.
J Neurosci. 2022 Mar 2;42(9):1864-1881. doi: 10.1523/JNEUROSCI.1324-21.2021. Epub 2022 Jan 18.
6
A proteogenomic portrait of lung squamous cell carcinoma.
Cell. 2021 Aug 5;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.
7
Inflammation and tumor progression: signaling pathways and targeted intervention.
Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5.
8
Overcoming Immune Evasion in Melanoma.
Int J Mol Sci. 2020 Nov 26;21(23):8984. doi: 10.3390/ijms21238984.
9
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.
Cancers (Basel). 2020 Jan 23;12(2):282. doi: 10.3390/cancers12020282.
10
A three-dimensional co-culture system to investigate macrophage-dependent tumor cell invasion.
J Biol Methods. 2016 Jul 24;3(3):e49. doi: 10.14440/jbm.2016.132. eCollection 2016.

本文引用的文献

1
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape.
Curr Opin Oncol. 2012 Nov;24(6):643-9. doi: 10.1097/CCO.0b013e3283589950.
2
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Blood. 2012 Oct 25;120(17):3501-9. doi: 10.1182/blood-2012-02-414060. Epub 2012 Sep 5.
3
Macrophage Migration and Its Regulation by CSF-1.
Int J Cell Biol. 2012;2012:501962. doi: 10.1155/2012/501962. Epub 2012 Feb 15.
4
CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways.
Crit Rev Clin Lab Sci. 2012 Mar-Apr;49(2):49-61. doi: 10.3109/10408363.2012.666845.
10
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
Blood. 2010 Sep 2;116(9):1460-8. doi: 10.1182/blood-2009-06-222943. Epub 2010 May 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验